PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk

NACompletedINTERVENTIONAL
Enrollment

1,302

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

November 30, 2017

Conditions
Breast Cancer
Interventions
BEHAVIORAL

Breast Cancer Screening Decision Aid

The intervention will include access to the personal decision aid tool for patients in the intervention arm of the study, determined by the randomized physician schedule and the patient's appointment time.

Trial Locations (9)

19087

Internal Medicine Radnor, Radnor

Penn Health for Women, Radnor

19104

Edward S. Cooper Internal Medicine, Philadelphia

Family Medicine St. Leonard's Court, Philadelphia

Family Medicine, Philadelphia

Helen O. Dickens Center for Women's Health, Philadelphia

Penn Center for Primary Care, Philadelphia

Penn Internal Medicine Associates, Philadelphia

Penn OB/GYN Associates, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT01879189 - PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk | Biotech Hunter | Biotech Hunter